Moein Moghimi is a senior lecturer in at The School of Pharmacy, University of Brighton. Before joining Brighton he was the University Research Fellow at the Department of Pharmaceutical Sciences, University of Nottingham (UK). In the past 18 years, he has pioneered research in design and engineering of nanoparticulate delivery vehiches for parenteral site-specific targeting and medical imaging (splenotropic nanoparticles, lymphotropic agents and ‘phagocyte-resistant’ nanoparticles), and more recently in nanotoxicology of synthetic gene transfer vectors and lipid-based nanocarriers (stealth liposomes and lipid nanoparticles). He has published over 70 peer-reviewed original research papers and invited critical reviews in leading international journals as well as over 80 book chapters, business reports, editorials, and patents. Dr. Moghimi has served as invited theme editor for three issues of Advanced Drug Delivery Reviews (1995, 2000, and 2006), one issue of Current Drug Delivery (2005), and he is an editorial board member of the Journal of Liposome Research and Nanomedicine. He is also on the scientific advisory panel of Nanopharmaceuticals.com and Multimedia Distributed Knowledge Network in Nanotechnology-Nanopolis™ (France). In addition, Dr. Moghimi is actively a consultant to over 30 pharmaceutical, biotechnology, health, and food industries world-wide as well as investment banks, and has delivered more than 100 invited lectures in 20 countries. In 1985, he graduated in biochemistry from The University of Manchester (UK) and in 1989 completed a PhD in liposomes immunobiology at Charing Cross Hospital Medical School (Imperial College, University of London, UK).
|
|